Ketamine Side Effects: What Lasts Minutes vs Months
A timeline-based look at ketamine side effects — what fades in 30 minutes, what lingers days, and what long-term risks matter with monitored infusions. If you're researching ketamine side effects before a first infusion, the real question underneath is usually simpler: how long will this feel strange, and could anything stick around? This guide sorts side effects by duration — what fades in minutes, what lingers hours, and what long-term risks the evidence actually supports. It's written for people in the Boise and Eagle area weighing monitored ketamine therapy for depression, PTSD, chronic pain, or migraine. Quick Answer: How Long Do Ketamine Side Effects Last? Most side effects from a monitored infusion — dissociation, dizziness, nausea, blurred vision, and a temporary blood pressure rise — peak during the drip and settle within roughly 30 to 90 minutes after it ends. Mild grogginess or a dull headache can linger the rest of the day. Serious long-term concerns are documented mainly in frequent, high-dose, non-medical use rather than spaced clinical dosing. Sub-anesthetic ketamine is a dose far below what's used to induce surgical anesthesia, delivered by slow IV drip with continuous vital-sign monitoring. For depression, doses around 0.5 mg/kg infused over about 40 minutes are described in the clinical literature ( StatPearls ). TL;DR Short-term effects are same-day events. The strange, floaty part is measured in minutes, not days. See the four-phase side effect timeline Route changes the experience. IV, intranasal esketamine, and oral dosing differ in peak window and monitoring requirements. Compare side effects by delivery method Effects often ease across a treatment series. Many patients describe the first one or two sessions as the most disorienting. Read what a depression series involves Long-term harms track with misuse, not monitored care. Bladder damage and cognitive concerns come overwhelmingly from frequent high-dose exposure. Review the long-term evidence A few symptoms warrant a same-day phone call. Urinary pain, chest pain, or confusion past 24 hours are not "wait and see" items. Check the red-flag symptom table In This Article What Does the Ketamine Side Effect Timeline Actually Look Like? Which Side Effects Are Specific to IV Ketamine Infusions? What Side Effects Show Up During a Depression Treatment Series? Are There Long-Term Effects of Ketamine Therapy? Who Is at Higher Risk for Ketamine Side Effects? How Do Clinics Actually Reduce Side Effects? What Symptoms Should You Report Right Away? Frequently Asked Questions What Does the Ketamine Side Effect Timeline Actually Look Like? Side effects follow a fairly predictable curve: they rise with the drug level, peak near the end of dosing, then fall off as the body clears it. Thinking in phases is more useful than reading an alphabetical list of symptoms. Phase 1 — During the infusion (roughly 0–40 minutes). This is where the dissociative effects live. Dissociation refers to a temporary sense of distance from your body, thoughts, or surroundings — time may feel stretched, and sounds or colors may seem altered. Dizziness, blurred or double vision, and a mild rise in blood pressure and heart rate also cluster here. The esketamine prescribing information notes that blood pressure increases tend to peak around 40 minutes after dosing ( FDA label ). Phase 2 — Immediate recovery (about 40–90 minutes). The drip stops and the drug clears quickly. Most people describe the odd perceptual effects fading first, followed by steadier balance. Nausea, if it appears, is usually managed here. Phase 3 — Rest of the day (2–12 hours). What remains is typically mild: tiredness, a heavy-limbed feeling, a low-grade headache, or a slightly "off" sense of coordination. This is why driving is off the table for the remainder of the day. Phase 4 — Next 24–72 hours. Most people report feeling physically back to baseline by the next morning. Some describe vivid dreams or unusually light sleep the first night. If you want a fuller picture of the subjective experience rather than the symptom list, our guide to what a ketamine infusion actually feels like walks through it session by session. Frequency varies between individuals — not everyone experiences every effect, and intensity depends on dose, body weight, and personal sensitivity. Key takeaway: Acute ketamine side effects are front-loaded into the infusion itself and taper within about an hour and a half of the drip ending. Which Side Effects Are Specific to IV Ketamine Infusions? Intravenous delivery produces the most controllable drug levels, because it bypasses the absorption variability that comes with swallowing or absorbing a medication through tissue ( StatPearls ). That predictability cuts both ways: effects during the drip can feel more pronounced, but a clinician can slow or stop the infusion in real time. Effects most tied to the IV route include: Transient cardiovascular changes — a temporary rise in blood pressure and heart rate, which is why cuff readings are taken throughout. Nystagmus — Nystagmus is brief involuntary rapid eye movement that resolves as the drug clears. It looks alarming to a bystander and is usually unnoticed by the patient. Infusion-site discomfort — mild stinging or tenderness where the catheter sits. Dose-dependent dissociation — the higher the level in the bloodstream, the more pronounced the perceptual shift. Here's how the common delivery routes compare on the practical points that shape your day: Factor IV infusion Intranasal esketamine (SPRAVATO) Oral / sublingual ketamine Delivery Slow drip in-clinic, commonly ~40 min for depression protocols ( StatPearls ) Self-administered nasal spray under supervision ( FDA label ) Taken by mouth; absorption varies by individual Route-specific effects Infusion-site discomfort; dose adjusted mid-session Nasal discomfort, taste changes, vertigo listed among adverse reactions ( FDA label ) Bitterness and nausea are commonly discussed; less predictable levels In-office observation Continuous monitoring through recovery At least 2 hours post-dose, per the label ( FDA label ) Varies by program Driving Not for the remainder of the day Not until the next day after restful sleep ( FDA label ) Follow prescriber instruction Dose control mid-session Yes — rate can be changed Fixed per-device dosing No The tradeoff most people care about: with IV ketamine therapy , a clinician is watching vitals and can respond while you're still in the chair. That's the practical difference between an effect being managed and an effect being endured. Key takeaway: IV infusions concentrate side effects into a supervised window where dose and rate can be adjusted on the spot. What Side Effects Show Up During a Depression Treatment Series? Across a standard induction series of multiple infusions spaced over a few weeks, patients frequently describe the first one or two sessions as the most disorienting, with subsequent sessions feeling more familiar., with subsequent sessions feeling more familiar. Nothing about that pattern is guaranteed; response and tolerance vary between individuals, and your clinician calibrates dose accordingly. Beyond the physical effects already covered, a depression series brings a few experiences worth naming in advance: Emotional rawness after a session. Some patients describe feeling unusually open or tearful in the hours afterward. Vivid dreams or altered sleep on the night of treatment. Transient anxiety spikes. Anxiety is listed among adverse reactions in the esketamine prescribing information ( FDA label ). A dip a few days later. Some people report a low stretch several days after a session. Discuss this pattern with your provider rather than interpreting it alone. Dissociation intolerance. A small number of people find the dissociative experience unpleasant enough that they and their clinician change the plan. Depression itself is a serious medical condition with several established treatment paths, and ketamine is one option a clinician may consider when others haven't worked ( NIMH ). Suitability is determined in a clinical consultation, not from an article. For how a series is structured locally — screening, spacing, and follow-up — see our page on ketamine for depression in Boise and Eagle . Are There Long-Term Effects of Ketamine Therapy? The well-documented long-term harms — bladder injury, cognitive changes, and dependence — appear overwhelmingly in the context of frequent, high-dose, non-medical ketamine use rather than spaced medical dosing. That distinction is the single most important thing to understand when you read alarming headlines. Our deeper breakdown of the long-term effects of ketamine therapy covers the wellness-journey side of this question. Can Ketamine Damage the Bladder? Yes — bladder injury is a recognized risk of long-term ketamine exposure. The esketamine prescribing information notes that cases of interstitial or ulcerative cystitis have been reported with long-term off-label use or misuse of ketamine, and advises monitoring for urinary tract and bladder symptoms ( FDA label ). StatPearls likewise lists urinary tract and bladder effects among ketamine's documented adverse effects ( StatPearls ). The practical signals are lower abdominal pain, pain when passing urine, and needing to urinate more often. Reporting these early is what allows a provider to act rather than react. Does Ketamine Affect Memory Long-Term? Cognitive effects are documented with sustained heavy exposure. The esketamine label references impaired cognition reported in individuals with long-term ketamine abuse and advises monitoring for cognitive impairment ( FDA label ). Short-term memory fuzziness during and shortly after a session is a separate, expected acute effect that clears with the drug. What remains genuinely unknown is the picture beyond a few years of ongoing maintenance dosing. Long-horizon data on repeated therapeutic use is limited, and honest clinics say so. Is Ketamine Therapy Addictive? Ketamine carries real potential for abuse and misuse, which is why it is a controlled substance and why esketamine is dispensed only through a restricted program with in-clinic administration ( FDA label ). The structural safeguards matter: no take-home supply, fixed appointment spacing, and prescriber oversight. ⚠️ Important distinction: The frequency and dose patterns behind reported bladder and cognitive harms look nothing like a spaced, clinically supervised protocol. Do not use recreational-use data to estimate your own risk — and do not use that distinction to skip monitoring. Anyone with a history of substance use disorder should raise it directly during screening. It doesn't automatically rule out treatment, but it changes how a plan is built and watched. Key takeaway: Long-term risk is driven by cumulative exposure and frequency, which is exactly what a monitored protocol is designed to limit. Who Is at Higher Risk for Ketamine Side Effects? Risk rises with uncontrolled high blood pressure, certain cardiovascular conditions, a history of psychosis, active substance use disorder, and pregnancy. The esketamine label lists aneurysmal vascular disease, arteriovenous malformation, intracerebral hemorrhage history, and hypersensitivity among its contraindications, and notes it is not recommended in pregnancy ( FDA label ). A thorough screening conversation typically covers: Blood pressure reading taken at consultation, plus your history of hypertension. Cardiac and vascular history , including any prior aneurysm or hemorrhage. Psychiatric history — psychosis, mania, and bipolar diagnoses shape the plan. See our notes on screening considerations for bipolar disorder . Full medication review , including benzodiazepines and lamotrigine, which clinicians commonly discuss when planning ketamine treatment. Substance use history , honestly reported. Liver and thyroid status , and pregnancy status where relevan